Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long ‐Term Disease Control: An Observational Study

ConclusionThe use of reduced oral prednisone doses, which was possible by combining different therapies, reduced glucocorticoid‐related damage and improved CV prognosis without increasing damage caused by SLE.

Source: Arthritis Care and Research - March 7, 2018 Category: Rheumatology Authors: Ioana Ruiz ‐Arruza, Jesús Lozano, Ivan Cabezas‐Rodriguez, Jose‐Alejandro Medina, Amaia Ugarte, José‐Gabriel Erdozain, Guillermo Ruiz‐Irastorza Tags: Original Article Source Type: research